Human studies on probiotics: What is scientifically proven today?

Lactic Acid Bacteria Microbiological and Functional Aspects, Third Edition: Revised and Expanded

Volumn , Issue , 2004, Pages 515-530

  Salminen, Seppo ^a   Gorbach, S ^b   Lee, Yuan Kun ^c   Benno, Y ^d  

^a UNIVERSITY OF TURKU   (Finland)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d RIKEN BIORESOURCE CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85044449728     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Salminen, S.; Bouley, M.C.; Boutron-Rualt, M.C.; Cummings, J.; Franck, A.; Gibson, G.; Isolauri E.; Moreau, M-C.; Roberfroid, M.; Rowland, I. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 1998, (suppl 1), 147–171.
2. Diplock, A.T.; Aggett, P.; Ashwell, M.; Bornet, F.; Fern, E.; Roberfroid, M. Scientific concepts of functional foods in Europe: consensus document. Br. J. Nutr. 1999, 81 (suppl 1), S1–S27.
3. Salminen, S.; Ouwehand, A.; Benno, Y.; Lee, Y-K. Probiotics: how should they be defined? Trends Food Sci. Technol. 1999, 10, 1–4.
4. Fonden, R.; Mogensen, G.; Tanaka, R.; Salminen, S. Culture-containing dairy products—effect on intestinal microflora, human nutrition and health—current knowledge and future perspectives. Bull. Int. Dairy Fed. 2000, 352.
5. Ouwehand, A.; Bianchi Salvadori, B.; Fondén, R.; Mogensen, G.; Salminen, S.; Sellars, R.; Tanaka, R. Health effects of probiotics. Bull. IDF 2003, in press.
6. Ouwehand, A.C.; Kirjavainen, P.V., Shortt, C.; Salminen, S. Probiotics: mechanisms and established effects. Int. Dairy J. 1999, 9, 43–52.
7. Isolauri, E.; Kirjavainen, P.V.; Salminen, S. Probiotics—a role in the treatment of intestinal infection and inflammation? Gut. 2002, 50 (suppl 3), 354–359.
8. Guarner, F.; Malagelada, JR. Gut flora in health and disease. Lancet 2003, 361, 512–519.
9. Huang, J.S.; Bousvaros, A.; Lee, J.W.; Diaz, A.; Davidson, EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig. Dis. Sci. 2002, 47, 2625–2634.
10. Van Niel, C.W.; Fewudtner, C.; Garrison, M.M.; Christakis, DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109, 678–684.
11. Szajewska, H.; Mrukowicz, JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 2001, 33, S17–25.
12. De Roos, N.; Katan, M. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am. J. Clin. Nutr. 2000, 71, 405–411.
13. Rhoads, M.: Management of acute diarrhea in infants. J. Parenter. Enteral.Nutr. 1999, 23, S18–19.
14. Gremonini, F.; Caro, S.; Nista, E.C.; Bartolozzi, F.; Capelli, G.; Gasbarrini, G.; Gasbarrini, A. Meta-analysis: the effects of probiotic administration on antibiotic associated diarrhoea: Aliment Pharmacol. Ther. 2002, 16, 1461–1467.
15. D’Souza, A.L.; Rajkumar, C.; Cooke, J.; Bulpitt, CJ. Probiotics in the prevention of antibiotic associated diarrhoea: meta-analysis. Br. Med. J. 2002, 324, 1361.
16. Agerholm-Larsen, L.; Bell, M.L.; Grunwald, G.K.; Astrup A. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short term intervention studies: Eur. J. Clin. Nutr. 2000, 54, 856–860.
17. Isolauri, E.; Juntunen, M.; Rautanen, T. et al. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children. Pediatrics 1991, 88, 90–97.
18. Guandalini, S.; Pensabene, L.; Zikri, M.A.; Dias, J. et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 2000, 30, 54–60.
19. Pant, A.R.; Graham, S.M.; Allen, S.J. et al.: Lactobacillus GG and acute diarrhoea in young children in the tropics. J. Trop. Ped. 1996, 42, 162–165.
20. Kaila, M.; Isolauri, E.; Soppi, E. et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain. Pediatr. Res. 1992, 32, 141–144.
21. McFarland, L.: A review of the evidence of health claims for biotherapeutic agents. Microb. Ecol. Health Dis. 2000, 12, 65–76.
22. Shornikova, A.-V., Casas, I., Mykkänen, H., Salo, E.; Vesikari, T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 1997, 16, 1103–1107.
23. Siitonen, S.; Vapaatalo, H.; Salminen, S.; Gordin, A.; Saxelin, M.; Wikberg, R.; Kirkkola, A-M. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea. Ann. Med. 1990, 22, 57–60.
24. Arvola, T.; Laiho, K.; Torkkeli, S.; Mykkänen, H.; Salminen, S.; Maunula, I.; Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999, 104, 64.
25. Vanderhoof, J.; Whitney, D.; Antonson, D.; Hanner, T.; Lupo, J.; Young, R. Lactobacillus GG in the prevention of antibiotic associated diarrhea in children. J. Pediatr. 1999, 135, 564–568.
26. Black, F.T., Einarsson, K., Lidbeck, A., Orrhage, K.; Nord, C. Effects of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scand. J. Infect. Dis. 1991, 23, 247–254.
27. He, F.; Morita, H.; Hashimoto, H. et al.: Intestinal Bifidobacterium species induce varying cytokine production. J. Allergy Clin. Immunol. 2002, 109, 1035–1036.
28. Kirjavainen, P.V.; Arvola, T.; Salminen, S.J.; Isolauri, E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002, 51, 51–55.
29. Isolauri, E.; Rautava, S.; Kalliomaki, M.; Kirjavainen, P.; Salminen, S. Role of probiotics in food hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2002, 263–271.
30. Kalliomäki, M.; Kirjavainen, P.; Eerola, E. et al.: Distinct patterns of neonatal gut microflora in infants in whomatopy was and was not developing. J. Allergy Clin. Immunol. 2001, 107, 129–134.
31. Kalliomäki, M.; Salminen, S.; Kero, P. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357, 1076–1079.
32. Majamaa, H.; Isolauri, E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997, 99, 179–186.
33. Isolauri, E.; Arvola, T.; Sütas, Y.; Moilanen, E.; Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000, 30, 1604–1610.
34. Pelto, L.; Isolauri, E.; Lilius, E.M. et al.: Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 1998, 28, 1474–1479.
35. Hattori, K.; Yamamoto, A.; Sadai, M.; Taniuchi, S.; Kojima, T.; Kobayashi, Y.; Iwamoto, H.; Namba, K.; Yaeshima, T. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi. 2003, 52, 20–30.
36. Rautava, S.; Kalliomaki, M.; Isolauri, E.: Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol. 2002, 109, 119–121.
37. Kalliomäki, M.; Salminen, S.; Poussa, T.; Arvilommi, H.; Isolauri, E. Probiotics and prevention of atopic disease—a 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361, 1869–1871.
38. Laiho, K.; Ouwehand, A.; Salminen, S.; Isolauri, E. Inventing probiotic functional foods for patients with allergic disease. Ann. Allergy Asthma Immunol. 2002, 6 (suppl 1), 75–82.
39. Aso, Y.; Akaza, H.; Kotake, T.; Tsukamoto, T.; Imai, K.; Naito, S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a doubleblind trial. Eur. Urol. 1995, 27, 104–109.
40. Brigidi, P.; Vitali, B.; Swennen, E.; Bazzocchi, G.; Matteuzzi, D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res. Microbiol. 2001, 152, 735–741.
41. Kim, H.J.; Camilleri, M.; McKinzie, S.; Lempke, M.B.; Burton, D.D.; Thomforde, G.M.; Zinsmeister, A.R. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol. Ther. 2003, 17, 895–904.
42. O’Sullivan, M.A.; O’Morain, C.A. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dog Liver Dis. 2000, 32, 294–301.
43. Gionchetti, P.; Rizzello, F.; Helwig, U.; Venturi, A.; Lammers, K.M.; Brigidi, P.; Vitali, B.; Poggioli, G.; Miglioli, M.; Campieri, M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124, 1202–1209.
44. Salminen, E.; Elomaa, I.; Minkkinen, J.; Vapaatalo, H.; Salminen, S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin. Radiol. 1988, 39, 435–437.
45. Delia, P.; Sansotta, G.; Donato, V.; Messina, G.; Frosina, P.; Pergolizzi, S.; De Renzis, C.; Famularo, G. Prevention of radiation-induced diarrhea with the use of VSL#3, a new highpotency probiotic preparation. Am. J. Gastroenterol. 2002, 97, 2150–2152.
46. Delia, P.; Sansotta, G.; Donato, V.; Messina, G.; Frosina, P.; Pergolizzi, S.; De Renzis, C. Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience. Dig. Liver. Dis. 2002, 34 (suppl 2), S84–86.
47. Shanahan, F. Probiotics and inflammatory bowel disease: is there a scientific rational? Inflammatory bowel diseases. 2000, 6, 107–115.
48. Gupta, P.; Andrew, H.; Kirschner, B.S.; Guandalini, S. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 2000, 31, 453–457.
49. Saarela, M.; Lähteenmaki, L.; Crittenden, R.; Salminen, S.; Mattila-Sandholm, T. Gut bacteria and health foods—the European perspective. Int. J. Food Microbiol. 2002, 78, 99–11.
50. Malchow, HA.: Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J. Clin. Gastroenterol. 1997, 25, 653–658.
51. Prantera, C.; Scribano, M.L.; Falasco, G. et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut 2002, 51, 405–409.
52. Rembacken, B.J.; Snelling, A.M.; Hawkey, P.M. et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999, 354, 635–639.
53. Mitchetti, P.; Dorta, G.; Wiesel, P.; Brassart, D.; Wedu, E.; Herman, M.; Felley, C.; Porta, N.; Rouvet, M.; Blum, A.; Corthesy-Theulan, I. Efect of whey based supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999, 60, 203–209.
54. Gill, H.S.; Darragh, A.J.; Cross, ML.: Optimizing immunity and gut function in the elderly. J. Nutr. Health. Aging. 2001, 5, 80–91.
55. Gill, H.S.; Rutherfurd, K.J.; Cross, ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J. Clin. Immunol. 2001, 21, 264–271.
56. Gill, H.S.; Rutherfurd, K.J.; Cross, M.L.; Gopal, PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 2001, 74, 833–839.
57. Aso, Y.; Akazan, H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol. Int. 1992, 49, 125–129.
58. Isolauri, E.; Kaila, M.; Mykkänen, H.; Ling, W.H.; Salminen, S. Oral bacteriotherapy for viral gastroenteritis. Dig. Dis. Sci. 1994, 39, 2595–2600.
59. Kirjavainen, P.; Apostolou, E.; Salminen, S.; Isolauri, E. New approaches of probiotics—a novel approach in the management of food allergy. Allergy 1999, 54, 909–915.
60. Lee, Y.K.; Lim, C.Y.; Teng, W.L.; Ouwehand, A.C.; Tuomola, E.; Salminen, S.: Qualitative approach in the study of adhesion of lactic acid bacteria on intestinal cells and their competition with enterobacteria. Appl. Environm. Micr. 2000, 66 (9), 3692–3697.
61. Lim, B.K.; Mahendran, R.; Lee, Y.K.; Bay, BH. Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn. J. Cancer Res. 2002, 93, 36–41.
62. Ohashi, Y.; Nakai, S.; Tsukamoto, T.; Masumori, N.; Akaza, H.; Miyanaga, N.; Kitamura, T.; Kawabe, K.; Kotake, T.; Kuroda, M.; Naito, S.; Koga, H.; Saito, Y.; Nomata, K.; Kitagawa, M.; Aso, Y. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int. 2002, 68, 273–280.
63. Seow, S.W.; Rahmat, J.N.; Mohamed, A.A.; Mahendran, R.; Lee, Y.K.; Bay, BH. Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (bacillus Calmette-Guerin). J. Urol. 2002, 168, 2236–2239.
64. Isolauri, E.; Salminen, S.; Ouwehand, A.C. Microbialgut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 2004, 18, 299–313.